Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'METHYLENEDIOXYMETHAMPHETAMINE MDMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 233 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kavanagh, P; Dunne, J; Feely, J; Maguire, R; Corrigan, D; Keating, JJ; Meegan, MJ; Clancy, JM; Burdett, J
      Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland

      ADDICTION BIOLOGY
    2. Frei, E; Gamma, A; Pascual-Marqui, R; Lehmann, D; Hell, D; Vollenweider, FX
      Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

      HUMAN BRAIN MAPPING
    3. Maldonado, E; Navarro, JF
      MDMA ('ecstasy') exhibits an anxiogenic-like activity in social encountersbetween male mice

      PHARMACOLOGICAL RESEARCH
    4. Obergriesser, T; Ende, G; Braus, DF; Henn, FA
      Hippocampal H-1-MRSI in ecstasy users

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    5. Zemishlany, Z; Aizenberg, D; Weizman, A
      Subjective effects of MDMA ('ecstasy') on human sexual function

      EUROPEAN PSYCHIATRY
    6. Wrona, MZ; Dryhurst, G
      A putative metabolite of serotonin, tryptamine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: Possible relevance to the serotonergic neurotoxicity of methamphetamine

      CHEMICAL RESEARCH IN TOXICOLOGY
    7. Bai, FJ; Jones, DC; Lau, SS; Monks, TJ
      Serotonergic neurotoxicity of 3,4-(+/-) -methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

      CHEMICAL RESEARCH IN TOXICOLOGY
    8. Fletcher, PJ; Robinson, SR; Slippoy, DL
      Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitatesacquisition of intravenous cocaine self-administration in rats

      NEUROPSYCHOPHARMACOLOGY
    9. Taffe, MA; Weed, MR; Davis, S; Huitron-Resendiz, S; Schroeder, R; Parsons, LH; Henriksen, SJ; Gold, LH
      Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine(MDMA) treatment in rhesus monkeys

      NEUROPSYCHOPHARMACOLOGY
    10. Liechti, ME; Geyer, MA; Hell, D; Vollenweider, FX
      Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

      NEUROPSYCHOPHARMACOLOGY
    11. Callahan, BT; Cord, BJ; Ricaurte, GA
      Long-term impairment of anterograde axonal transport along fiber projection originating in the rostral raphe nuclei after treatment with fenfluramineor methylenedioxymethamphetamine

      SYNAPSE
    12. Shankaran, M; Yamamoto, BK; Gudelsky, GA
      Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT

      SYNAPSE
    13. Fornai, F; Giorgi, FS; Gesi, M; Chen, K; Alessandri, MG; Shih, JC
      Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice

      SYNAPSE
    14. Kalant, H
      The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    15. Tancer, ME; Johanson, CE
      The subjective effects of MDMA and mCPP in moderate MDMA users

      DRUG AND ALCOHOL DEPENDENCE
    16. Fernandez, F; Aguerre, S; Mormede, P; Chaouloff, F
      Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains

      NEUROSCIENCE LETTERS
    17. Pentney, AR
      An exploration of the history and controversies surrounding MDMA and MDA

      JOURNAL OF PSYCHOACTIVE DRUGS
    18. O'Loinsigh, ED; Boland, G; Kelly, JP; O'Boyle, KM
      Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    19. Teter, CJ; Guthrie, SK
      A comprehensive review of MDMA and GHB: Two common club drugs

      PHARMACOTHERAPY
    20. Broening, HW; Morford, LL; Inman-Wood, SL; Fukumura, M; Vorhees, CV
      3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development

      JOURNAL OF NEUROSCIENCE
    21. MacInnes, N; Handley, SL; Harding, GFA
      Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

      JOURNAL OF PSYCHOPHARMACOLOGY
    22. Connor, TJ; Connelly, DB; Kelly, JP
      Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG(2a) and IFN-gamma production

      IMMUNOLOGY LETTERS
    23. Zhao, HR; Brenneisen, R; Scholer, A; McNally, AJ; ElSohly, MA; Murphy, TP; Salamone, SJ
      Profiles of urine samples taken from ecstasy users at rave parties: Analysis by immunoassays, HPLC, and GC-MS

      JOURNAL OF ANALYTICAL TOXICOLOGY
    24. Buchert, R; Obrocki, J; Thomasius, R; Vaterlein, O; Petersen, K; Jenicke, L; Bohuslavizki, KH; Clausen, M
      Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET

      NUCLEAR MEDICINE COMMUNICATIONS
    25. Russell, BR; Laverty, R
      The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    26. Gold, MS; Tabrah, H; Frost-Pineda, K
      Psychopharmacology of MDMA (Ecstasy)

      PSYCHIATRIC ANNALS
    27. O'Shea, E; Esteban, B; Camarero, J; Green, AR; Colado, MI
      Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

      NEUROPHARMACOLOGY
    28. Ling, LH; Marchant, C; Buckley, NA; Prior, M; Irvine, RJ
      Poisoning with the recreational drug paramethoxyamphetamine ("death")

      MEDICAL JOURNAL OF AUSTRALIA
    29. Harkin, A; Connor, TJ; Mulrooney, J; Kelly, JP; Leonard, BE
      Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

      LIFE SCIENCES
    30. Rajamani, K; Leong, S; Lavelle, A; Docherty, JR
      Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. Al-Sahli, W; Ahmad, H; Kheradmand, F; Connolly, C; Docherty, JR
      Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery

      EUROPEAN JOURNAL OF PHARMACOLOGY
    32. Connor, TJ; Dennedy, MC; Harkin, A; Kelly, JP
      Methylenedioxymethamphetamine-induced suppression of interleukin-1 beta and tumour necrosis factor-alpha is not mediated by serotonin

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Sanchez, V; Camarero, J; Esteban, B; Peter, MJ; Green, AR; Colado, MI
      The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    34. Yamada, J; Sugimoto, Y; Ohkura, M; Inoue, K; Shinozuka, K; Kunitomo, M
      Role of 5-HT2 receptor subtypes in depletion of 5-HT induced by p-chloroamphetamine in the mouse frontal cortex

      BRAIN RESEARCH
    35. McCann, UD; Ricaurte, GA; Molliver, ME
      "Ecstasy" and serotonin neurotoxicity - New findings raise more questions

      ARCHIVES OF GENERAL PSYCHIATRY
    36. Cadet, JL; Thiriet, N; Jayanthi, S
      Involvement of free radicals in MDMA-induced neurotoxicity in mice

      ANNALES DE MEDECINE INTERNE
    37. Lin, CH; Chung, YL; Chen, YH
      Development of a capillary electrophoresis-77 K luminescence detection system for online spectral identification

      ANALYST
    38. Croft, RJ; Klugman, A; Baldeweg, T; Gruzelier, JH
      Electrophysiological evidence of serotonergic impairment in long-term MDMA("ecstasy") users

      AMERICAN JOURNAL OF PSYCHIATRY
    39. Colado, MI; O'Shea, E; Esteban, B; Green, AR
      Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-inducedneurodegeneration in rat brain

      PSYCHOPHARMACOLOGY
    40. Mechan, AO; O'Shea, E; Elliott, JM; Colado, MI; Green, AR
      A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation

      PSYCHOPHARMACOLOGY
    41. Liechti, ME; Gamma, A; Vollenweider, FX
      Gender differences in the subjective effects of MDMA

      PSYCHOPHARMACOLOGY
    42. Croft, RJ; Mackay, AJ; Mills, ATD; Gruzelier, JGH
      The relative contributions of ecstasy and cannabis to cognitive impairment

      PSYCHOPHARMACOLOGY
    43. Verkes, RJ; Gijsman, HJ; Pieters, MSM; Schoemaker, RC; de Visser, S; Kuijpers, M; Pennings, EJM; de Bruin, D; Van de Wijngaart, G; Van Gerven, JMA; Cohen, AF
      Cognitive performance and serotonergic function in users of ecstasy

      PSYCHOPHARMACOLOGY
    44. Van Aerts, LAGJM; Mallaret, M; Rigter, H
      N-methyl-1-(1,3-benzodioxol-5-yl)-2-buta (MBDB): its properties and possible risks

      ADDICTION BIOLOGY
    45. Grob, CS
      Deconstructing ecstasy: The politics of MDMA research

      ADDICTION RESEARCH
    46. Gamma, A; Frei, E; Lehmann, D; Pascual-Marqui, RD; Hell, D; Vollenweider, FX
      Mood state and brain electric activity in Ecstasy users

      NEUROREPORT
    47. Fischer, HS; Zernig, G; Schatz, DS; Humpel, C; Saria, A
      MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum

      EUROPEAN JOURNAL OF NEUROSCIENCE
    48. McCann, UD; Ricaurte, GA
      Drug abuse and dependence: hazards and consequences of heroin, cocaine andamphetamines

      CURRENT OPINION IN PSYCHIATRY
    49. Buchler, J; Maichle-Mossmer, C; Kovar, KA
      Enantioselective production and crystal structure of the ecstasy analogue N-ethyl-3,4-methylenedioxyamphetamine-HCl (MDE) and its major metabolites MDA and HME

      ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
    50. Burgess, C; O'Donohoe, A; Gill, M
      Agony and ecstasy: a review of MDMA effects and toxicity

      EUROPEAN PSYCHIATRY
    51. Dulawa, SC; Gross, C; Stark, KL; Hen, R; Geyer, MA
      Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition

      NEUROPSYCHOPHARMACOLOGY
    52. Iravani, MM; Asari, D; Patel, J; Wieczorek, WJ; Kruk, ZL
      Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin ordopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulate, and the dorsal raphe nucleus slices

      SYNAPSE
    53. Schatz, DS; Kaufmann, WA; Schuligoi, R; Humpel, C; Saria, A
      3,4-methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices

      SYNAPSE
    54. Shannon, M
      Methylenedioxymethamphetamine (MDMA, "Ecstasy")

      PEDIATRIC EMERGENCY CARE
    55. Graeme, KA
      New drugs of abuse

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    56. Ricaurte, GA; McCann, UD; Szabo, Z; Scheffel, U
      Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

      TOXICOLOGY LETTERS
    57. Parrott, AC; Sisk, E; Turner, JJD
      Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

      DRUG AND ALCOHOL DEPENDENCE
    58. Ricaurte, GA; Yuan, J; McCann, UD
      (+/-)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Studies in animals

      NEUROPSYCHOBIOLOGY
    59. Parrott, AC
      Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: Cognitive and behavioural indices of change

      NEUROPSYCHOBIOLOGY
    60. Curran, HV
      Is MDMA ('ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

      NEUROPSYCHOBIOLOGY
    61. Maldonado, E; Navarro, JF
      Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    62. Cami, J; Farre, M; Mas, M; Roset, PN; Poudevida, S; Mas, A; San, L; de la Torre, R
      Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): Psychomotor performance and subjective effects

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    63. Brown, P; Molliver, ME
      Dual serotonin (5-HT) projections to the nucleus accumbens core and shell:Relation of the 5-HT transporter to amphetamine-induced neurotoxicity

      JOURNAL OF NEUROSCIENCE
    64. Xie, T; McCann, UD; Kim, S; Yuan, J; Ricaurte, GA
      Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity

      JOURNAL OF NEUROSCIENCE
    65. Asanuma, M; Hayashi, T; Ordonez, SV; Ogawa, N; Cadet, JL
      Direct interactions of methamphetamine with the nucleus

      MOLECULAR BRAIN RESEARCH
    66. Erdtmann-Vourliotis, M; Mayer, P; Riechert, U; Hollt, V
      Prior experience of morphine application alters the c-fos response to MDMA('ecstasy') and cocaine in the rat striatum

      MOLECULAR BRAIN RESEARCH
    67. Conner, TJ; Kelly, JP; Leonard, BE
      An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats

      IMMUNOPHARMACOLOGY
    68. Valentine, JL; Middleton, R
      GC-MS identification of sympathomimetic amine drugs in urine: Rapid methodology applicable for emergency clinical toxicology

      JOURNAL OF ANALYTICAL TOXICOLOGY
    69. Boot, BP; McGregor, LS; Hall, W
      MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

      LANCET
    70. Beitia, G; Cobreros, A; Sainz, L; Cenarruzabeitia, E
      Ecstasy-induced toxicity in rat liver

      LIVER
    71. Kelly, PAT
      Does recreational ecstasy use cause long-term cognitive problems?

      WESTERN JOURNAL OF MEDICINE
    72. Glennon, RA; Young, R
      MDMA stimulus generalization to the 5-HT1A serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    73. Byrne, T; Baker, LE; Poling, A
      MDMA and learning: Effects of acute and neurotoxic exposure in the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    74. Barrionuevo, M; Aguirre, N; Del Rio, J; Lasheras, B
      Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: A comparison with MDMA

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    75. O'Cain, PA; Hletko, SB; Ogden, BA; Varner, KJ
      Cardiovascular and sympathetic responses and reflex changes elicited by MDMA

      PHYSIOLOGY & BEHAVIOR
    76. Connor, TJ; Kelly, JP; McGee, M; Leonard, BE
      Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1 beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge

      LIFE SCIENCES
    77. Kelly, PAT
      Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    78. Gouzoulis-Mayfrank, E; Daumann, J; Tuchtenhagen, F; Pelz, S; Becker, S; Kunert, HJ; Fimm, B; Sass, H
      Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    79. Hervias, I; Lasheras, B; Aguirre, N
      2-deoxy-D-glucose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity

      JOURNAL OF NEUROCHEMISTRY
    80. Morley, KC; McGregor, IS
      (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases socialinteraction in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    81. Shirayama, Y; Hashimoto, K; Iyo, M; Watanabe, K; Higuchi, T; Minabe, Y
      3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    82. Slotkin, TA; Seidler, FJ; Ali, SF
      Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions

      BRAIN RESEARCH
    83. Harvey, DC; Lacan, G; Tanious, SP; Melega, WP
      Recovery from methamphetamine induced long-term nigrostriatal dopaminergicdeficits without substantia nigra cell loss

      BRAIN RESEARCH
    84. Kalia, M; O'Callaghan, JP; Miller, DB; Kramer, M
      Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry

      BRAIN RESEARCH
    85. Gerra, G; Zaimovic, A; Ferri, M; Zambelli, U; Timpano, M; Neri, E; Marzocchi, GF; Delsignore, R; Brambilla, F
      Long-lasting effects of (+/-)3,4-methylene-dioxymethamphetamine (ecstasy) on serotonin system function in humans

      BIOLOGICAL PSYCHIATRY
    86. Kreth, KP; Kovar, KA; Schwab, M; Zanger, UM
      Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

      BIOCHEMICAL PHARMACOLOGY
    87. Morgan, MJ
      Ecstasy (MDMA): a review of its possible persistent psychological effects

      PSYCHOPHARMACOLOGY
    88. Sexton, TJ; McEvoy, C; Neumaier, JF
      (+)3,4-Methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain

      MOLECULAR PSYCHIATRY
    89. Chang, L; Ernst, T; Grob, CS; Poland, RE
      Cerebral H-1 MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") users

      JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING
    90. Walubo, A; Seger, D
      Fatal multi-organ failure after suicidal overdose with MDMA, 'Ecstasy': case report and review of the literature

      HUMAN & EXPERIMENTAL TOXICOLOGY
    91. Aguirre, N; Barrionuevo, M; Ramirez, MJ; Del Rio, J; Lasheras, B
      alpha-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

      NEUROREPORT
    92. Virden, TB; Baker, LE
      Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine

      BEHAVIOURAL PHARMACOLOGY
    93. Colado, MI; Granados, R; O'Shea, E; Esteban, B; Green, AR
      The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA,"eve") on body temperature and long term degeneration of 5-HT neurones in brain: Acomparison with MDMA ("ecstasy")

      PHARMACOLOGY & TOXICOLOGY
    94. Bai, FJ; Lau, SS; Monks, TJ
      Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: Possible role in methylenedioxyamphetamine-mediated neurotoxicity

      CHEMICAL RESEARCH IN TOXICOLOGY
    95. Stumm, G; Schlegel, J; Schafer, T; Wurz, C; Mennel, HD; Krieg, JC; Vedder, H
      Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons

      FASEB JOURNAL
    96. Yeh, SY; Dersch, C; Rothman, R; Cadet, JL
      Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats

      SYNAPSE
    97. Yeh, SY
      N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats

      SYNAPSE
    98. RATTRAY M; MICHAEL GJ; LEE J; WOTHERSPOON G; BENDOTTI C; PRIESTLEY JV
      INTRAREGIONAL VARIATION IN EXPRESSION OF SEROTONIN TRANSPORTER MESSENGER-RNA BY 5-HYDROXYTRYPTAMINE NEURONS

      Neuroscience
    99. Stephenson, CP; Hunt, GE; Topple, AN; McGregor, IS
      The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain

      NEUROSCIENCE
    100. Jayanthi, S; Ladenheim, B; Andrews, AM; Cadet, JL
      Overexpression of human copper zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy)

      NEUROSCIENCE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 03:33:13